The short version of actin binding fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-07-29 and is reviewed periodically as new material appears.
Controlled human trials of the short fragment are scarce. Much of what appears in review articles is extrapolated from animal models or from studies of the parent protein, and literature searches return a larger body of cardiac and ophthalmic work on thymosin beta-4 than on the abbreviated peptide. Regulatory treatment differs by jurisdiction, and in several countries the material is handled as a research chemical rather than an approved therapeutic. Statements about human benefit should be read as provisional.
Biological interest in this peptide centers on its relationship to actin dynamics. Thymosin beta-4 binds monomeric actin through an LKKTET motif, and a short sequence carrying that motif can compete with other actin-binding proteins in cell-free preparations. Investigators propose that such competition shifts the balance between filament assembly and disassembly, which in turn affects how readily a cell extends protrusions and migrates. Most of the supporting observations come from cultured cells and purified protein systems rather than from intact organisms.
Research interest in thymosin beta-4 fragments centres on actin sequestration, cell migration and tissue repair models. Most published work uses cultured cells or animal wound and cardiac preparations, and findings are generally described as preliminary. No fragment of this protein has been approved as a therapeutic product by major regulators. Reviews of the field note inconsistent dosing, delivery routes and outcome measures across studies, which complicates direct comparison. The material is best understood as a laboratory reagent with an active but unresolved research literature.
TB-500 is a catalogue name applied to a synthetic peptide related to thymosin beta-4, an actin-binding protein found in most mammalian cells. Suppliers do not use the label consistently: some describe it as the full 43-residue protein, others as a short fragment from the actin-binding region, and others as a related tetrapeptide. Because the name is commercial rather than chemical, two products sold under it may not contain the same molecule. This naming ambiguity is the first point to check in any description of the material.
| Property | Value | Notes |
|---|---|---|
| Common synonyms | Thymosin beta-4 fragment; TB4 fragment | Naming is inconsistent across suppliers and publications |
| Reported sequence | Ac-LKKTETQ | Corresponds to residues 17-23 of the parent protein |
| Frequently cited registry number | 77591-33-4 | Associated with full-length thymosin beta-4 rather than the fragment |
| Common supplied form | Freeze-dried solid | Often presented as an acetate or trifluoroacetate salt |
| Regulatory treatment | Varies by country | Frequently handled as a research chemical; not broadly approved as a therapeutic |
Discussion of TB-500 appears in several distinct literatures that rarely cite one another. Peer-reviewed studies usually describe in vitro assays or small animal experiments and are cautious about extrapolation. Veterinary and sports communities circulate anecdotal reports with limited methodological detail. Commercial listings add a third layer, often using the name interchangeably with thymosin beta-4 even though the two molecules differ in size and sequence. Regulatory status varies by country, and the compound is not a licensed medicine in most jurisdictions, so readers comparing sources should check which molecule and which purity each source actually describes.
TB-500 is a synthetic seven-residue peptide whose sequence, LKKTETQ, matches the N-terminal actin-binding region of thymosin beta-4. It is usually supplied in an N-terminally acetylated form, a modification that blocks the free amino terminus and can influence behavior in solution. In the research literature the same sequence appears under several names, including thymosin beta-4 fragment and shortened thymosin beta-4. Because it is a short peptide rather than the full 43-residue parent protein, its measured properties differ from those reported for thymosin beta-4 as a whole, and the two are not interchangeable in experimental design.
Thymosin beta-4 itself is a small, widely expressed protein that sequesters monomeric actin and participates in cell migration, angiogenesis, and tissue repair. Researchers have examined the shortened fragment as a possible mimic of some of these activities, reasoning that the actin-binding motif lies within the first few residues. Binding to monomeric actin has been observed in cell-free systems. Whether the fragment reproduces the broader effects of the full protein in living tissue remains an open question, and findings from animal models are frequently cited without a clear bridge to human physiology.
Purity and identity are separate measurements and are often confused. Reverse-phase high-performance liquid chromatography, usually with ultraviolet detection near 214 nanometres, reports the share of total peak area belonging to the target compound. Mass spectrometry by electrospray or matrix-assisted laser desorption then checks whether the observed mass matches the expected sequence. Neither measurement alone shows that a vial holds the intended peptide. Peptide content, meaning the fraction of vial mass that is genuine peptide rather than counter-ion, water or residual acid, is reported separately and is frequently lower than the stated purity figure.
The regulatory position is broadly consistent across major jurisdictions: no thymosin beta-4 fragment is an approved medicine, and laboratory material is commonly labelled as not intended for human consumption. Anti-doping rules in sport list thymosin beta-4 and its fragments among prohibited peptide hormones. Because these products travel through research-chemical channels rather than pharmaceutical supply chains, quality varies considerably between vendors. Independent testing of identity, purity and sterility is the only dependable check, and a certificate of analysis describes one batch rather than a supplier's whole catalogue.
Lyophilized peptide powder is normally held desiccated at −20 °C, with −80 °C used for longer storage periods. Allowing a sealed vial to reach room temperature before opening is standard practice, because condensation forming on cold powder introduces moisture. Once dissolved, solutions are typically kept cold and shielded from light. Repeated freeze-thaw cycles are avoided because they encourage aggregation and gradual loss of material. These conventions are general to synthetic peptides rather than unique to any one sequence.
The compound is most often distributed as a lyophilized powder, appearing white to off-white and forming a loose cake or fluffy solid. It is hygroscopic to some degree, so brief exposure to humid air can add water weight and complicate weighing. The peptide dissolves readily in water and in neutral aqueous buffers, and aqueous solubility is generally described as high, well above the concentrations used in typical assays. Some polar organic solvents are also usable, which matters when a concentrated stock is prepared before dilution into buffer.
Storage recommendations center on keeping the dry powder cold, dry, and dark. A freezer at -20 degrees Celsius or below is conventional, and desiccant is often included to limit moisture uptake. Once dissolved, the peptide is less stable, and solutions are typically kept frozen and thawed only once. Repeated freeze-thaw cycles are a common source of losses because they promote aggregation and adsorption to container surfaces. Working aliquots are therefore prepared in advance, and glass or low-binding plastic is usually preferred over ordinary laboratory plastic.
TB-500 is a short synthetic peptide sold under a trade name rather than a systematic chemical name. Suppliers usually describe it as a fragment of thymosin beta-4 and ship it as a lyophilised powder intended for laboratory use. Because the label is commercial, the exact sequence attributed to it is not fully consistent across catalogues, and some listings present a seven-residue peptide while others describe related fragments of similar length. It is not an approved medicine in any major jurisdiction, and it is handled as a research chemical.
Thymosin beta-4 itself is a natural peptide of 43 residues found in many cell types and body fluids. Its best-characterised function is binding and sequestering actin monomers, which influences cytoskeletal dynamics. The sequence most often associated with TB-500, LKKTETQ, corresponds to part of that actin-binding region. A different fragment, Ac-SDKP, is also derived from the same parent peptide and is studied in its own right, which is one reason discussions of thymosin fragments can become confusing. The two are structurally distinct and are not interchangeable.
Interest in the fragment grew during the 1990s and 2000s, when it moved from laboratory work into sports and supplement markets. Anti-doping bodies added thymosin beta-4 fragments to prohibited lists, and a small number of adverse analytical findings have been reported in competition testing. Published controlled human trials remain scarce. Most mechanistic evidence comes from cell culture and animal models, and those studies examine endpoints such as cell migration, wound closure and inflammation markers. That evidence supports research interest but does not establish clinical benefit, and broad regenerative claims should be read as unverified.
=== Feud with the House and Marcos-Duterte rift === A rift between the Duterte and Marcos families had begun under House Speaker Martin Romualdez' leadership. In the House of Representatives, unconfirmed reports of Deputy House Speaker Gloria-Macapagal Arroyo allegedly attempting to unseat Romualdez as House Speaker circulated. Despite Arroyo dismissing the accusations, Arroyo was later demoted by the House from her senior deputy Speaker position. Duterte's daughter, Vice President and Education Secretary Sara, subsequently resigned from the Romualdez-led Lakas-CMD and, in a veiled reference to Romualdez, called him a "tambaloslos" (A term that can be interpreted as a joke or as an insult, depending on context). In October 2023, Sara requested Congress for the allocation of confidential funds for the office of the vice president (OVP) and the education department which can be used for the Reserve Officers' Training Corps program. Her requests came under intense scrutiny by the Senate and the House, which was dominated by Romualdez's allies. Congress ultimately rejected her appeals while swiftly approving the confidential funds of the Office of the President; Sara eventually dropped her requests, reasoning that the move was being "divisive". In the aftermath of events, Duterte criticized the House for denying his daughter's confidential funds; alleging a collusion between Romualdez and the left-wing Makabayan bloc, he demanded an audit of the House under Romualdez.
Generative AI systems have been used in mathematics and computer science to generate candidate computer programs, proofs, constructions, or algorithms. In 2023, Google DeepMind introduced FunSearch, a method for creating computer programs that solve mathematical and algorithmic problems. FunSearch was used to discover new mathematical constructions in the cap set problem and the bin packing problem. In 2023, Google DeepMind introduced AlphaDev, which was used to discover small sorting algorithms that outperformed previously known human benchmarks and have been integrated into the LLVM standard C++ sorting library. In 2025, Google DeepMind introduced AlphaEvolve, an AI system for general-purpose algorithm discovery and optimization. AlphaEvolve uses LLMs to propose code changes, automated evaluators to assess each candidate, and an evolutionary process to iteratively improve algorithms. In 2026, in response to the increasing use of generative AI in mathematical discovery, a group of mathematicians issued the Leiden Declaration on Artificial Intelligence and Mathematics, which recommends disclosing the use of AI in research papers, ensuring that AI-assisted papers are peer-reviewed, and providing legal resources and public funding so that academia and for-profit companies can compete on equal terms.
== Early life and education == Abdel Fattah al-Burhan was born in 1960 in the village of Gandatu in northern Sudan, to a Ja'ali family. Al-Burhan studied elementary and intermediate level in his village school, and later moved to Shendi to complete his education before joining the Sudanese Military College.
Platelet-mimicking particles are bioengineered constructs that functionally replicate the size, shape, and mechanical properties of natural platelets, which assist various hemostatic mechanisms. Also known as synthetic platelets, these biosynthetic particles are recent advancements in the field of drug delivery where they enable targeted interactions that enhance hemostasis, minimize bleeding risks, and support localized therapies. Their applications extend to thrombosis, inflammation, and cancer treatment, as well as significant potential in trauma care, cardiovascular therapies, and immunotherapy. They also address limitations of natural platelet transfusions, such as limited availability, short shelf life, and safety concerns. The design and manufacture of platelet-mimicking particles is diverse across current methods and involves precise biomaterial selection, nanoparticle engineering, surface functionalization, and scalable production techniques. Many of these designs include decorating microspheres with specialized antibodies and peptides that can bind to circulating tumor cells and facilitate their removal or altering their shape upon thrombin exposure to accelerate wound healing. Another approach engineers these platelets with a discoidal shape and flexible polymer composition to mimic platelet deformation under shear forces. While these varied approaches aim to optimize surface interactions and hemostatic performance for multiple therapeutic applications, current research on synthetic platelets is primarily in the preclinical stage.
He was re-elected from Kalaghatgi in 2023 and appointed Labour Minister in the second Siddaramaiah ministry. He subsequently continued in the Labour portfolio after the 2026 reconstitution of the Karnataka cabinet, where the Karnataka Legislative Assembly lists him as Minister for Labour and Employment.
Sources: en.wikipedia.org
Jammu and Kashmir (princely state), for the entity that existed till 1952 Kashmiriyat Kashmiri cinema Literature of Kashmir Music of Jammu and Kashmir Kus Bani Koshur Karorpaet AIR Srinagar Central University of Kashmir Central University of Jammu Jammu and Kashmir cricket team Real Kashmir F.C. Jammu and Kashmir football team Jammu and Kashmir Light Infantry Jammu and Kashmir Rifles Fauna of Jammu and Kashmir Mansar-Surinsar Wildlife Sanctuary
Anthranilic acid is an aromatic acid with the formula C6H4(NH2)(CO2H) and has a sweetish taste. The molecule consists of a benzene ring, ortho-substituted with a carboxylic acid and an amine. As a result of containing both acidic and basic functional groups, the compound is amphoteric. Anthranilic acid is a white solid when pure, although commercial samples may appear yellow. The anion [C6H4(NH2)(CO2)]−, obtained by the deprotonation of anthranilic acid, is called anthranilate. Anthranilic acid was once thought to be a vitamin and was referred to as vitamin L1 in that context, but it is now known to be non-essential in human nutrition.
The peptidyl transferase center (EC 2.3.2.12, PTC) is an aminoacyltransferase ribozyme (RNA enzyme) located in the large subunit of the ribosome. It forms peptide bonds between adjacent amino acids during the translation process of protein biosynthesis. Peptidyl transferase activity is not mediated by any ribosomal proteins, but entirely by ribosomal RNA (rRNA). The catalytic activity of the PTC is a significant piece of evidence supporting the RNA World hypothesis. The PTC is a highly conserved region with a very slow rate of mutation. It is considered to be among the most ancient elements of the ribosome, predating the last universal common ancestor. The position of the PTC is analogous in all ribosomes (domain V in 23S numbering), being a part of the large subunit ribosomal RNA with the name only varying due to the different size in Svedberg. It acts as a ribozyme at the lower tips (acceptor ends) of the A- and P- site tRNAs. The different names include:
Animals that characterize the Appalachian forests include five species of tree squirrels. The most commonly seen is the low to moderate elevation eastern gray squirrel (Sciurus carolinensis). Occupying similar habitat is the slightly larger fox squirrel (Sciurus niger) and the much smaller southern flying squirrel (Glaucomys volans). More characteristic of cooler northern and high elevation habitat is the red squirrel (Tamiasciurus hudsonicus), whereas the Appalachian northern flying squirrel (Glaucomys sabrinus fuscus), which closely resembles the southern flying squirrel, is confined to northern hardwood and spruce–fir forests. As familiar as squirrels are the eastern cottontail rabbit (Silvilagus floridanus) and the white-tailed deer (Odocoileus virginianus). The latter in particular has greatly increased in abundance as a result of the extirpation of the eastern wolf (Canis lupus lycaon) and the North American cougar. This has led to the overgrazing and browsing of many plants of the Appalachian forests, as well as destruction of agricultural crops. Other deer include the moose (Alces alces ), found only in the north, and the elk (Cervus canadensis), which, although once extirpated, is now making a comeback, through transplantation, in the southern and central Appalachians. In Quebec, the Chic-Chocs host the only population of reindeer (Rangifer tarandus) south of the St. Lawrence River. An additional species that is common in the north but extends its range southward at high elevations to Virginia and West Virginia is the varying or snowshoe hare (Lepus americanus).
== Universities == According to the 2020 QS World University Rankings, Chulalongkorn University (CU) was ranked 247th in the world and earned the top ranking in Thailand for the seventh consecutive year. Also ranked were Mahidol University (314th), and Chiang Mai University and Thammasat University (both in the 601–650 tranche), and four other Thai universities in the 801–1,000 tranche. The Times Higher Education Asia University Rankings 2018 ranked Mahidol University as the top Thai institution. It ranked 97 of some 350 universities (1=best; 350=lowest). King Mongkut's University of Technology Thonburi was ranked 116, Chulalongkorn University 164, and Suranaree University of Technology 168. Thailand had no other universities in the top 200. Chulalongkorn University was ranked number one in Thailand and 45th in Asia in 2016. Mahidol University was ranked the top Thai university among the top 200 Asian (including Middle Eastern) universities in 2016 by Times Higher Education Asia University Rankings 2016.
Sources: en.wikipedia.org
The leading proposal involves sequestration of monomeric actin, which would alter cytoskeletal turnover and cell movement. The actin-binding motif shared with the parent protein is central to that idea. Direct confirmation in whole organisms remains limited.
Very few controlled human studies focus on the seven-residue sequence itself. Most clinical data concern the full-length protein in cardiac or ophthalmic settings. Conclusions drawn for one form should not be assumed to transfer to the other.
Detection normally relies on reversed-phase liquid chromatography paired with mass spectrometry. Chromatographic retention time establishes the expected elution window, and the mass spectrum confirms the molecular ion. Immunoassays exist but can cross-react with related peptides.
TB-500 is a trade-style label for a synthetic peptide connected to thymosin beta-4. It is sold mainly through research-chemical channels and is not a single chemically defined product across suppliers.